|
1
|
Van den Eynden GG, Majeed AW, Illemann M,
Vermeulen PB, Bird NC, Høyer-Hansen G, Eefsen RL, Reynolds AR and
Brodt P: The multifaceted role of the microenvironment in liver
metastasis: Biology and clinical implications. Cancer Res.
73:2031–2043. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Colangelo T, Polcaro G, Muccillo L,
D'Agostino G, Rosato V, Ziccardi P, Lupo A, Mazzoccoli G, Sabatino
L and Colantuoni V: Friend or foe? The tumour microenvironment
dilemma in colorectal cancer. Biochim Biophys Acta. 1867:1–18.
2017.PubMed/NCBI
|
|
3
|
Trautmann F, Cojoc M, Kurth I, Melin N,
Bouchez LC, Dubrovska A and Peitzsch C: CXCR4 as biomarker for
radioresistant cancer stem cells. Int J Radiat Biol. 90:687–699.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Brand S, Dambacher J, Beigel F, Olszak T,
Diebold J, Otte JM, Göke B and Eichhorst ST: CXCR4 and CXCL12 are
inversely expressed in colorectal cancer cells and modulate cancer
cell migration, invasion and MMP-9 activation. Exp Cell Res.
310:117–130. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ottaiano A, Franco R, Aiello Talamanca A,
Liguori G, Tatangelo F, Delrio P, Nasti G, Barletta E, Facchini G,
Daniele B, et al: Overexpression of both CXC chemokine receptor 4
and vascular endothelial growth factor proteins predicts early
distant relapse in stage II–III colorectal cancer patients. Clin
Cancer Res. 12:2795–2803. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yamada S, Shimada M, Utsunomiya T, Morine
Y, Imura S, Ikemoto T, Mori H, Arakawa Y, Kanamoto M, Iwahashi S
and Saito Y: CXC receptor 4 and stromal cell-derived factor 1 in
primary tumors and liver metastases of colorectal cancer. J Surg
Res. 187:107–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li JK, Yu L, Shen Y, Zhou LS, Wang YC and
Zhang JH: Inhibition of CXCR4 activity with AMD3100 decreases
invasion of human colorectal cancer cells in vitro. World J
Gastroenterol. 14:2308–2313. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wendel C, Hemping-Bovenkerk A, Krasnyanska
J, Mees ST, Kochetkova M, Stoeppeler S and Haier J: CXCR4/CXCL12
participate in extravasation of metastasizing breast cancer cells
within the liver in a rat model. PLoS One. 7:e300462012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
O'Boyle G, Swidenbank I, Marshall H,
Barker CE, Armstrong J, White SA, Fricker SP, Plummer R, Wright M
and Lovat PE: Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by
AMD11070. Br J Cancer. 108:1634–1640. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olaso E, Salado C, Egilegor E, Gutierrez
V, Santisteban A, Sancho-Bru P, Friedman SL and Vidal-Vanaclocha F:
Proangiogenic role of tumor-activated hepatic stellate cells in
experimental melanoma metastasis. Hepatology. 37:674–685. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Puche JE, Saiman Y and Friedman SL:
Hepatic stellate cells and liver fibrosis. Compr Physiol.
3:1473–1492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song Y, Kim SH, Kim KM, Choi EK, Kim J and
Seo HR: Activated hepatic stellate cells play pivotal roles in
hepatocellular carcinoma cell chemoresistance and migration in
multicellular tumor spheroids. Sci Rep. 6:367502016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cojoc M, Peitzsch C, Trautmann F,
Polishchuk L, Telegeev GD and Dubrovska A: Emerging targets in
cancer management: role of the CXCL12/CXCR4 axis. Onco Targets
Ther. 6:1347–1361. 2013.PubMed/NCBI
|
|
14
|
Mishra P, Banerjee D and Ben-Baruch A:
Chemokines at the crossroads of tumor-fibroblast interactions that
promote malignancy. J Leukoc Biol. 89:31–39. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kusmartsev S and Gabrilovich DI: Effect of
tumor-derived cytokines and growth factors on differentiation and
immune suppressive features of myeloid cells in cancer. Cancer
Metastasis Rev. 25:323–331. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhang H, Li Z, Wang L, Tian G, Tian J,
Yang Z, Cao G, Zhou H, Zhao L, Wu Z and Yin Z: Critical role of
myeloid-derived suppressor cells in tumor-induced liver immune
suppression through inhibition of NKT cell function. Front Immunol.
8:1292017.PubMed/NCBI
|
|
17
|
Goodwin TJ, Zhou Y, Musetti SN, Liu R and
Huang L: Local and transient gene expression primes the liver to
resist cancer metastasis. Sci Transl Med. 8:364ra1532016.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
D'Alterio C, Barbieri A, Portella L, Palma
G, Polimeno M, Riccio A, Ieranò C, Franco R, Scognamiglio G, Bryce
J, et al: Inhibition of stromal CXCR4 impairs development of lung
metastases. Cancer Immunol Immunother. 61:1713–1720. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Smedsrød B and Pertoft H: Preparation of
pure hepatocytes and reticuloendothelial cells in high yield from a
single rat liver by means of Percoll centrifugation and selective
adherence. J Leukoc Biol. 38:213–230. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arteta B, Lasuen N, Lopategi A,
Sveinbjörnsson B, Smedsrød B and Vidal-Vanaclocha F: Colon
carcinoma cell interaction with liver sinusoidal endothelium
inhibits organ-specific antitumor immunity through
interleukin-1-induced mannose receptor in mice. Hepatology.
51:2172–2182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xu Y, Zhao W, Xu J, Li J, Hong Z, Yin Z
and Wang X: Activated hepatic stellate cells promote liver cancer
by induction of myeloid-derived suppressor cells through
cyclooxygenase-2. Oncotarget. 7:8866–8878. 2016.PubMed/NCBI
|
|
22
|
Zhang SS, Han ZP, Jing YY, Tao SF, Li TJ,
Wang H, Wang Y, Li R, Yang Y, Zhao X, et al: CD133(+)CXCR4(+) colon
cancer cells exhibit metastatic potential and predict poor
prognosis of patients. BMC Med. 10:852012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kollmar O, Rupertus K, Scheuer C, Junker
B, Tilton B, Schilling MK and Menger MD: Stromal cell-derived
factor-1 promotes cell migration and tumor growth of colorectal
metastasis. Neoplasia. 9:862–870. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Oh JW, Drabik K, Kutsch O, Choi C, Tousson
A and Benveniste EN: CXC chemokine receptor 4 expression and
function in human astroglioma cells. J Immunol. 166:2695–2704.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Odemis V, Moepps B, Gierschik P and Engele
J: Interleukin-6 and cAMP induce stromal cell-derived factor-1
chemotaxis in astroglia by up-regulating CXCR4 cell surface
expression. Implications for brain inflammation. J Biol Chem.
277:39801–39808. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hong F, Tuyama A, Lee TF, Loke J, Agarwal
R, Cheng X, Garg A, Fiel MI, Schwartz M, Walewski J, et al: Hepatic
stellate cells express functional CXCR4: Role in stromal
cell-derived factor-1alpha-mediated stellate cell activation.
Hepatology. 49:2055–2067. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun X, Cheng G, Hao M, Zheng J, Zhou X,
Zhang J, Taichman RS, Pienta KJ and Wang J: CXCL12/CXCR4/CXCR7
chemokine axis and cancer progression. Cancer Metastasis Rev.
29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Gassmann P, Haier J, Schlüter K,
Domikowsky B, Wendel C, Wiesner U, Kubitza R, Engers R, Schneider
SW, Homey B and Müller A: CXCR4 regulates the early extravasation
of metastatic tumor cells in vivo. Neoplasia. 11:651–661.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Alsayed Y, Ngo H, Runnels J, Leleu X,
Singha UK, Pitsillides CM, Spencer JA, Kimlinger T, Ghobrial JM,
Jia X, et al: Mechanisms of regulation of CXCR4/SDF-1
(CXCL12)-dependent migration and homing in multiple myeloma. Blood.
109:2708–2717. 2007.PubMed/NCBI
|
|
30
|
Marra F and Tacke F: Roles for chemokines
in liver disease. Gastroenterology. 147:577–594.e1. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wu Y, Peng H, Cui M, Whitney NP, Huang Y
and Zheng JC: CXCL12 increases human neural progenitor cell
proliferation through Akt-1/FOXO3a signaling pathway. J Neurochem.
109:1157–1167. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Heinrich EL, Lee W, Lu J, Lowy AM and Kim
J: Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated
signaling pathways in pancreatic cancer cells. J Transl Med.
10:682012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Valcárcel M, Arteta B, Jaureguibeitia A,
Lopategi A, Martínez I, Mendoza L, Muruzabal FJ, Salado C and
Vidal-Vanaclocha F: Three-dimensional growth as multicellular
spheroid activates the proangiogenic phenotype of colorectal
carcinoma cells via LFA-1-dependent VEGF: Implications on hepatic
micrometastasis. J Transl Med. 6:572008. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saiman Y, Agarwal R, Hickman DA, Fausther
M, El-Shamy A, Dranoff JA, Friedman SL and Bansal MB: CXCL12
induces hepatic stellate cell contraction through a
calcium-independent pathway. Am J Physiol Gastrointest Liver
Physiol. 305:G375–G382. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yuan X, Xiao T, Dai F, Yu Y and Lou J:
CXCL12α and CXCL12β stimulate the migration of cultured LX-2
hepatic stellate cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
31:293–296. 2015.(In Chinese). PubMed/NCBI
|
|
36
|
Zhang J, Sarkar S and Yong VW: The
chemokine stromal cell derived factor-1 (CXCL12) promotes glioma
invasivenessthrough MT2-matrix metalloproteinase. Carcinogenesis.
26:2069–2077. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Teng F, Tian WY, Wang YM, Zhang YF, Guo F,
Zhao J, Gao C and Xue FX: Cancer-associated fibroblasts promote the
progression of endometrial cancer via the SDF-1/CXCR4 axis. J
Hematol Oncol. 9:82016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sun X, Cheng G, Hao M, Zheng J, Zhou X,
Zhang J, Taichman RS, Pienta KJ and Wang J: CXCL12/CXCR4/CXCR7
chemokine axis and cancer progression. Cancer Metastasis Rev.
29:709–722. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ma L, Qiao H, He C, Yang Q, Cheung CH,
Kanwar JR and Sun X: Modulating the interaction of CXCR4 and CXCL12
by low-molecular-weight heparin inhibits hepatic metastasis of
colon cancer. Invest New Drugs. 30:508–517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Heckmann D, Maier P, Laufs S, Li L,
Sleeman JP, Trunk MJ, Leupold JH, Wenz F, Zeller WJ, Fruehauf S and
Allgayer H: The disparate twins: A comparative study of CXCR4 and
CXCR7 in SDF-1α-induced gene expression, invasion and
chemosensitivity of colon cancer. Clin Cancer Res. 20:604–616.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Liang Z, Brooks J, Willard M, Liang K,
Yoon Y, Kang S and Shim H: CXCR4/CXCL12 axis promotes VEGF-mediated
tumor angiogenesis through Akt signaling pathway. Biochem Biophys
Res Commun. 359:716–722. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lang A, Sakhnini E, Fidder HH, Maor Y,
Bar-Meir S and Chowers Y: Somatostatin inhibits pro-inflammatory
cytokine secretion from rat hepatic stellate cells. Liver Int.
25:808–816. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chou HS, Hsieh CC, Yang HR, Wang L,
Arakawa Y, Brown K, Wu Q, Lin F, Peters M, Fung JJ, et al: Hepatic
stellate cells regulate immune response by way of induction of
myeloid suppressor cells in mice. Hepatology. 53:1007–1019. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Sawanobori Y, Ueha S, Kurachi M, Shimaoka
T, Talmadge JE, Abe J, Shono Y, Kitabatake M, Kakimi K, Mukaida N
and Matsushima K: Chemokine-mediated rapid turnover of
myeloid-derived suppressor cells in tumor-bearing mice. Blood.
111:5457–5466. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yang L, Huang J, Ren X, Gorska AE, Chytil
A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC and Moses
HL: Abrogation of TGF beta signaling in mammary carcinomas recruits
Gr-1+CD11b+ myeloid cells that promote
metastasis. Cancer Cell. 13:23–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ba H, Li B, Li X, Li C, Feng A, Zhu Y,
Wang J, Li Z and Yin B: Transmembrane tumor necrosis factor-α
promotes the recruitment of MDSCs to tumor tissue by upregulating
CXCR4 expression via TNFR2. Int Immunopharmacol. 44:143–152. 2017.
View Article : Google Scholar : PubMed/NCBI
|
